A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma. (2020)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers12041029
PubMed Identifier: 32331483
Publication URI: http://europepmc.org/abstract/MED/32331483
Type: Journal Article/Review
Volume: 12
Parent Publication: Cancers
Issue: 4
ISSN: 2072-6694